Lixisenatide Subcutaneous and Zoledronic Acid (Bone Health)
Determining the interaction of Lixisenatide Subcutaneous and Zoledronic Acid (Bone Health) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic acid, Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lixisenatide Subcutaneous-Zoledronic Acid (Zometa)
- Lixisenatide Subcutaneous-Zoledronic Acid Injection
- Lixisenatide Subcutaneous-Zoledronic Acid Injection Concentrate
- Lixisenatide Subcutaneous-Zoledronic acid Intravenous
- Lixisenatide Subcutaneous-Zoledronic Acid IV
- Lixisenatide Subcutaneous-Zolgensma
- Zoledronic Acid (Bone Health)-Lixtraxen Injection
- Zoledronic Acid (Bone Health)-LMD
- Zoledronic Acid (Bone Health)-LMD Injection
- Zoledronic Acid (Bone Health)-LMX 4 Topical application
- Zoledronic Acid (Bone Health)-LMX 5
- Zoledronic Acid (Bone Health)-LMX 5 Topical application